Nancy Le
About Nancy Le
Nancy Le is a QA Specialist III in Computer Systems Validation at Ardelyx, Inc., with over four years of experience in this role. She has a background in QA validation engineering and pharmaceutical validation consulting, and holds a Bachelor of Science degree from California State University, Los Angeles.
Work at Ardelyx
Nancy Le has been employed at Ardelyx, Inc. since 2020, serving as a QA Specialist III in Computer Systems Validation. In this role, she is responsible for ensuring the quality and compliance of computer systems used within the organization. Her tenure at Ardelyx spans four years, during which she has contributed to the company's quality assurance efforts in Fremont, California.
Current Role at Intarcia Therapeutics
In addition to her position at Ardelyx, Nancy Le works as a QA Validation Engineer at Intarcia Therapeutics, Inc. since 2019. She has accumulated five years of experience in this role, focusing on quality assurance and validation processes in Hayward, California. Her work involves ensuring that the systems and processes meet regulatory standards.
Previous Experience at Hyde Engineering + Consulting
Prior to her current roles, Nancy Le worked at Hyde Engineering + Consulting as a Pharmaceutical Validation Consultant from 2015 to 2019. During her four years in Boulder, Colorado, she provided expertise in validation processes within the pharmaceutical sector, contributing to the compliance and quality of various projects.
Early Career at Starbucks
Nancy Le began her career at Starbucks, where she held the position of Shift Manager from 2006 to 2011. Over the course of five years in San Jose, California, she managed daily operations, supervised staff, and ensured customer satisfaction, gaining valuable management experience.
Education and Expertise
Nancy Le earned a Bachelor of Science degree from California State University, Los Angeles. Her educational background provides a foundation for her expertise in quality assurance and validation within the pharmaceutical and biotechnology industries.